Archives
- 2018-07
- 2019-06
- 2019-07
- 2019-08
- 2019-09
- 2019-10
- 2019-11
- 2019-12
- 2020-01
- 2020-02
- 2020-03
- 2020-04
- 2020-05
- 2020-06
- 2020-07
- 2020-08
- 2020-09
- 2020-10
- 2020-11
- 2020-12
- 2021-01
- 2021-02
- 2021-03
- 2021-04
- 2021-05
- 2021-06
- 2021-07
- 2021-08
- 2021-09
- 2021-10
- 2021-11
- 2021-12
- 2022-01
- 2022-02
- 2022-03
- 2022-04
- 2022-05
- 2022-06
- 2022-07
- 2022-08
- 2022-09
- 2022-10
- 2022-11
- 2022-12
- 2023-01
- 2023-02
- 2023-03
- 2023-04
- 2023-05
- 2023-06
- 2023-07
- 2023-08
- 2023-09
- 2023-10
- 2023-11
- 2023-12
- 2024-01
- 2024-02
- 2024-03
- 2024-04
- 2024-05
- 2024-06
- 2024-07
- 2024-08
- 2024-09
- 2024-10
- 2024-11
-
The Oct 17 Comment by Chris
2019-06-29
The Oct 17 Comment by Chris Collins and Chris Beyrer raises several important challenges associated with strengthening country ownership and accelerating progress in the global HIV/AIDS response. Working together with our partners, the US President\'s Emergency Plan for AIDS Relief (PEPFAR) is firmly committed to help address these challenges as we take steps to enhance the sustainability of HIV/AIDS programmes.
-
Conflict of interest Introduction Landiolol
2019-06-28
Conflict of interest Introduction Landiolol is an intravenous short-acting beta-adrenoreceptor blocker, and its wide use is exhibited by rapid wash out and a less-sustained effect on cardiac function after decreasing the dose or stopping its administration [1]. We present a patient with drug-resistant and persistent inappropriate sinus tachycardia (IST), who also had palpitations.
-
Safety of continuation of warfarin during
2019-06-27
Safety of continuation of warfarin during the perioperative period of pacemaker and defibrillator surgery An increasing body of literature has suggested that pacemaker and defibrillator Cocktail without cessation of oral anticoagulation is safe and feasible. Goldstein et al. were among the first to report their experience implanting devices in 37 patients continued on warfarin with a mean INR of 2.5 at the time of device surgery and compared to 113 patients who did not receive warfarin. The incidence of pocket hematoma in warfarin continuation group was not significantly different from the controls [16]. Al-Khadra reported similar findings in 47 patients with a mean INR 2.3 at device implantation [17].
-
Hello world!
2018-07-29
13969 records 932/932 page Previous First page 上5页 931932